UY33274A - Proteínas de unión a basigina - Google Patents

Proteínas de unión a basigina

Info

Publication number
UY33274A
UY33274A UY0001033274A UY33274A UY33274A UY 33274 A UY33274 A UY 33274A UY 0001033274 A UY0001033274 A UY 0001033274A UY 33274 A UY33274 A UY 33274A UY 33274 A UY33274 A UY 33274A
Authority
UY
Uruguay
Prior art keywords
basigin
antibodies
proteins
union
union proteins
Prior art date
Application number
UY0001033274A
Other languages
English (en)
Inventor
Chung-Ming Hsieh
Eve H Barlow
Gillian Ann Kingsbury
Edward B Reilly
Susan Morgan-Lappe
Denise D Karaoglu Hanzatian
Fritz G Buchanan
Li Yingchun
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY33274A publication Critical patent/UY33274A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Proteínas de unión aisladas, por ejemplo, anticuerpos, que se unen a la basigina (BSG), por ejemplo, la BSG2 humana, y composiciones y moléculas basadas en anticuerpos relacionadas. También se divulgan composiciones farmacéuticas que comprenden los anticuerpos, así como métodos terapéuticos y de diagnóstico para el uso de los anticuerpos.
UY0001033274A 2010-03-11 2011-03-11 Proteínas de unión a basigina UY33274A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31293210P 2010-03-11 2010-03-11
US36356010P 2010-07-12 2010-07-12

Publications (1)

Publication Number Publication Date
UY33274A true UY33274A (es) 2011-09-30

Family

ID=44560208

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033274A UY33274A (es) 2010-03-11 2011-03-11 Proteínas de unión a basigina

Country Status (5)

Country Link
US (1) US20110223176A1 (es)
AR (1) AR080680A1 (es)
TW (1) TW201134489A (es)
UY (1) UY33274A (es)
WO (1) WO2011112566A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015500655A (ja) * 2011-12-21 2015-01-08 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 同起源の抗体可変領域遺伝子セグメントをクローニングおよび発現させるための迅速な方法
US10365275B2 (en) 2013-03-12 2019-07-30 Institute of Arthritis Reasearch, LLC Immunologically active polypeptide
US20190127461A1 (en) * 2016-04-06 2019-05-02 Order-Made Medical Research Inc. Cancer treatment pharmaceutical composition using anti-mct5 antibody
CN105820250B (zh) * 2016-04-29 2019-04-30 中国人民解放军第四军医大学 一种抗basigin人源化抗体及其应用
CN108261544B (zh) * 2016-12-30 2023-05-05 江苏太平洋美诺克生物药业股份有限公司 稳定的包含cd147单克隆抗体的药物制剂
CN108261391B (zh) * 2016-12-30 2022-03-01 江苏太平洋美诺克生物药业有限公司 稳定的包含cd147单克隆抗体的药物制剂
WO2018165619A1 (en) * 2017-03-09 2018-09-13 Cytomx Therapeutics, Inc. Cd147 antibodies, activatable cd147 antibodies, and methods of making and use thereof
MX2020008274A (es) 2018-02-07 2020-11-11 Regeneron Pharma Metodos y composiciones para la administracion de proteinas terapeuticas.
CN110674726A (zh) * 2019-09-20 2020-01-10 清华大学 基于目标检测与迁移学习的皮肤病辅助诊断方法及系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322749A1 (en) * 1998-03-03 1999-09-10 Abgenix, Inc. Cd147 binding molecules as therapeutics
US20050026215A1 (en) * 2003-07-17 2005-02-03 Predki Paul F. Method for the prediction of an epitope
US7241598B2 (en) * 2004-06-29 2007-07-10 The Chinese University Of Hong Kong Frame-shifting PCR for germline immunoglobulin genes retrieval and antibody engineering
EP1784425A4 (en) * 2004-06-30 2009-02-18 Centocor Inc ANTI-MCP-1 ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP2297209A4 (en) * 2008-06-03 2012-08-01 Abbott Lab IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF

Also Published As

Publication number Publication date
WO2011112566A2 (en) 2011-09-15
US20110223176A1 (en) 2011-09-15
AR080680A1 (es) 2012-05-02
TW201134489A (en) 2011-10-16
WO2011112566A3 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
UY33274A (es) Proteínas de unión a basigina
CY1122490T1 (el) Αντισωματα κατα του ανθρωπινου cd38
CY1123739T1 (el) Αντισωματα anti-cd38
CY1122278T1 (el) Αντι il-36r αντισωματα
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
UY32971A (es) Proteínas de unión al antígeno de la il-23 humana
ECSP12012272A (es) Proteínas que se unen al tnf-?
ECSP14001249A (es) Inmunoenlazadores dirigidos contra el tnf
CY1118014T1 (el) Aνti-il-23 αντισωματα
CR20140585A (es) Proteinas de union a antigeno st2
BR112015012933A2 (pt) proteínas de ligação ao antígeno bcma
AR090923A1 (es) Anticuerpos anti-il-23
PE20150360A1 (es) Agentes de union de proteina de r-espondina humana (rsp03) y usos de los mismos
BRPI0919473A2 (pt) Agentes de ligação frizzled e usos dos mesmos
CL2014001930A1 (es) Formulacion farmacéutica que comprende un anticuerpo angiopoyetina 2 (anti-ang2).
BR112013005699A2 (pt) moléculas de ligação a 4-1bb
CL2013000369A1 (es) Anticuerpo que se une especificamente a la proteina de activacion fibroblastica (fap); polinucleotido que lo codifica; vector; celula huesped; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar cancer.
CL2011002943A1 (es) Anticuerpo triespecifico o tetraespecifico; metodo para la preparacion de dicho anticuerpo; celula huesped; composicion farmaceutica.
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
ECSP11011445A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c3b
CR20110358A (es) Proteinas de enlace de miostatina
BR112014006822A2 (pt) proteínas de ligação ao antígeno cd27l
BR112016015105A2 (pt) Conjugados var2csa-droga
CO6721048A2 (es) Anticuerpos que se unen a notum pectinacetilesterasa
AR121799A2 (es) Proteínas de unión a antígenos de il-23 humana

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191217